Prot# XL999-207: A Phase 2 Study of XL999 Administered Intravenously to Subjects with Acute Myeloid Leukemia

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/25/067/25/09

Funding

  • PPD Development (XL999-207)
  • Exelixis Inc. (XL999-207)